Lilly, Biologics expand collaboration over cancer drugs in China

Eli Lilly (LLY) and Innovent Biologics (IVBIY) are expanding their strategic partnership for certain cancer drugs. Under the agreement, Innovent will get sole commercialization rights...

Related Keywords

China ,Innovent Biologics ,Eli Lilly ,Company Research Laboratories ,Company Research ,Stock Editorial ,